从小处着手:利用精确有限样本可能性在随机实验中优先考虑安全性而非有效性

Neil Christy, A. E. Kowalski
{"title":"从小处着手:利用精确有限样本可能性在随机实验中优先考虑安全性而非有效性","authors":"Neil Christy, A. E. Kowalski","doi":"arxiv-2407.18206","DOIUrl":null,"url":null,"abstract":"We use the exact finite sample likelihood and statistical decision theory to\nanswer questions of ``why?'' and ``what should you have done?'' using data from\nrandomized experiments and a utility function that prioritizes safety over\nefficacy. We propose a finite sample Bayesian decision rule and a finite sample\nmaximum likelihood decision rule. We show that in finite samples from 2 to 50,\nit is possible for these rules to achieve better performance according to\nestablished maximin and maximum regret criteria than a rule based on the\nBoole-Frechet-Hoeffding bounds. We also propose a finite sample maximum\nlikelihood criterion. We apply our rules and criterion to an actual clinical\ntrial that yielded a promising estimate of efficacy, and our results point to\nsafety as a reason for why results were mixed in subsequent trials.","PeriodicalId":501293,"journal":{"name":"arXiv - ECON - Econometrics","volume":"61 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Starting Small: Prioritizing Safety over Efficacy in Randomized Experiments Using the Exact Finite Sample Likelihood\",\"authors\":\"Neil Christy, A. E. Kowalski\",\"doi\":\"arxiv-2407.18206\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"We use the exact finite sample likelihood and statistical decision theory to\\nanswer questions of ``why?'' and ``what should you have done?'' using data from\\nrandomized experiments and a utility function that prioritizes safety over\\nefficacy. We propose a finite sample Bayesian decision rule and a finite sample\\nmaximum likelihood decision rule. We show that in finite samples from 2 to 50,\\nit is possible for these rules to achieve better performance according to\\nestablished maximin and maximum regret criteria than a rule based on the\\nBoole-Frechet-Hoeffding bounds. We also propose a finite sample maximum\\nlikelihood criterion. We apply our rules and criterion to an actual clinical\\ntrial that yielded a promising estimate of efficacy, and our results point to\\nsafety as a reason for why results were mixed in subsequent trials.\",\"PeriodicalId\":501293,\"journal\":{\"name\":\"arXiv - ECON - Econometrics\",\"volume\":\"61 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"arXiv - ECON - Econometrics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/arxiv-2407.18206\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"arXiv - ECON - Econometrics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/arxiv-2407.18206","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

我们使用精确的有限样本似然法和统计决策理论,利用随机实验数据和优先考虑安全过度的效用函数来回答 "为什么 "和 "你应该怎么做 "的问题。我们提出了有限样本贝叶斯决策规则和有限样本最大似然决策规则。我们的研究表明,在 2 到 50 个有限样本中,与基于布尔-弗雷谢特-霍夫定边界的规则相比,根据既定的最大化和最大遗憾标准,这些规则有可能取得更好的性能。我们还提出了一种有限样本最大似然准则。我们将我们的规则和标准应用于一项实际的临床试验,该试验得出了令人鼓舞的疗效估计值,我们的结果表明,安全性是导致后续试验结果参差不齐的一个原因。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Starting Small: Prioritizing Safety over Efficacy in Randomized Experiments Using the Exact Finite Sample Likelihood
We use the exact finite sample likelihood and statistical decision theory to answer questions of ``why?'' and ``what should you have done?'' using data from randomized experiments and a utility function that prioritizes safety over efficacy. We propose a finite sample Bayesian decision rule and a finite sample maximum likelihood decision rule. We show that in finite samples from 2 to 50, it is possible for these rules to achieve better performance according to established maximin and maximum regret criteria than a rule based on the Boole-Frechet-Hoeffding bounds. We also propose a finite sample maximum likelihood criterion. We apply our rules and criterion to an actual clinical trial that yielded a promising estimate of efficacy, and our results point to safety as a reason for why results were mixed in subsequent trials.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信